CH678855A5 - - Google Patents

Download PDF

Info

Publication number
CH678855A5
CH678855A5 CH4236/89A CH423689A CH678855A5 CH 678855 A5 CH678855 A5 CH 678855A5 CH 4236/89 A CH4236/89 A CH 4236/89A CH 423689 A CH423689 A CH 423689A CH 678855 A5 CH678855 A5 CH 678855A5
Authority
CH
Switzerland
Prior art keywords
formula
compound
metabolite
preparation
hydroxyl group
Prior art date
Application number
CH4236/89A
Other languages
German (de)
English (en)
Inventor
Maximilian Dr Grassberger
Gerhard Dr Schulz
Theodor Dr Fehr
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH678855A5 publication Critical patent/CH678855A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/445—The saccharide radical is condensed with a heterocyclic radical, e.g. everninomycin, papulacandin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CH4236/89A 1988-11-29 1989-11-27 CH678855A5 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3840185 1988-11-29
DE3917779 1989-05-31

Publications (1)

Publication Number Publication Date
CH678855A5 true CH678855A5 (ko) 1991-11-15

Family

ID=25874647

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4236/89A CH678855A5 (ko) 1988-11-29 1989-11-27

Country Status (6)

Country Link
JP (1) JPH02275884A (ko)
BE (1) BE1003436A3 (ko)
CH (1) CH678855A5 (ko)
FR (1) FR2639637A1 (ko)
GB (1) GB2225576B (ko)
IT (1) IT1237429B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2245891A (en) * 1990-07-09 1992-01-15 Fujisawa Pharmaceutical Co Tricyclo compounds
GB2246350A (en) * 1990-07-23 1992-01-29 Fujisawa Pharmaceutical Co Tricyclo compounds
US5023262A (en) * 1990-08-14 1991-06-11 American Home Products Corporation Hydrogenated rapamycin derivatives
CA2051872A1 (en) * 1990-09-24 1992-03-25 Kevin M. Byrne Directed biosynthesis process for prolyl-immunomycin
US5527820A (en) * 1992-06-23 1996-06-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Antibiotics having immunosuppressive activity, delaminomycins and processes for the production of the same
AU670597B2 (en) * 1992-06-24 1996-07-25 Ferring B.V. Novel benzodiazepine derivative
EP1474404A4 (en) 2002-02-13 2006-01-11 Biogal Gyogyszergyar PROCESS FOR EXTRACTION OF A BIOLOGICAL MATERIAL
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
AU630866B2 (en) * 1987-12-09 1992-11-12 Fisons Plc Macrocyclic compounds
EP0349061B1 (en) * 1988-06-29 1995-03-29 Merck & Co. Inc. Immunosuppressant agent
US4981792A (en) * 1988-06-29 1991-01-01 Merck & Co., Inc. Immunosuppressant compound
EP0353678B1 (en) * 1988-08-01 1995-12-13 Fujisawa Pharmaceutical Co., Ltd. FR-901154 and FR-901155 substances, a process for their production
EP0358508A3 (en) * 1988-09-08 1991-03-20 Merck & Co. Inc. Novel immunosuppressant compound

Also Published As

Publication number Publication date
GB2225576B (en) 1992-07-01
JPH02275884A (ja) 1990-11-09
IT1237429B (it) 1993-06-04
GB8926787D0 (en) 1990-01-17
FR2639637A1 (fr) 1990-06-01
IT8948610A0 (it) 1989-11-29
GB2225576A (en) 1990-06-06
FR2639637B1 (ko) 1994-08-19
BE1003436A3 (fr) 1992-03-24

Similar Documents

Publication Publication Date Title
JP2767161B2 (ja) 抗寄生虫活性ピロロベンゾキサジン化合物
EP0131181B1 (de) Anthracyclin-Derivate, ein mikrobiologisches Verfahren zu ihrer Herstellung und ihre Verwendung als Cytostatika
CH678855A5 (ko)
EP0196628A2 (de) Ein neues Ansamycin-Antibiotikum, ein mikrobielles Verfahren zu seiner Herstellung und seine Verwendung als Arzneimittel
CH668598A5 (de) Antitumor-antibiotika.
EP0652205A2 (de) Moenomycin-Abbauprodukte mit hydroxylierter oder oxidierter Lipidseitenkette und Moenomycin-Analoga, ein Verfahren zur Herstellung und die Verwendung dieser Verbindungen
DE69816621T2 (de) Macrolide mit antitumoraktivität
DE60004669T2 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
EP1280812A1 (de) Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben
DE3621024A1 (de) 11(beta)-phenyl-estrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3041130C2 (ko)
EP1049707B1 (de) Ustilipide, verfahren zu deren herstellung sowie deren verwendung
DE3938754A1 (de) Substituierte azatricycloderivate und metaboliten, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
EP0829486A2 (de) Neue Polyenantibiotika, 3874 H1 bis H6, Verfahren zu ihrer Herstellung und Verwendung
EP0482543B1 (de) Oasomycine, Verfahren zu ihrer Herstellung und ihre Verwendung
DE60132703T2 (de) Citrullimycine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0339442A2 (de) Neue Angucyclinone aus Streptomyceten, Verfahren zu ihrer Herstellung und ihre Vewendung
EP0546474A1 (de) Pseurotin F1/F2, neue Metabolite aus Aspergillus fumigatus, Verfahren zu ihrer Herstellung und ihre Verwendung als Apomorphin Antagonisten
DE4225284A1 (de) Clonostachydiol und Helmidiol, neue Makrodiolide mit pharmakologischer Wirkung, ein Verfahren zu ihrer Herstellung und ihre Verwendung
EP0546475A1 (de) Biologisch aktives Pseurotin A und D, neue Metabolite aus Aspergillus fumigatus, Verfahren zu ihrer Herstellung und ihre Verwendung als Apomorphin Antagonisten
EP0212293A2 (de) Verfahren zur mikrobiellen Hydroxylierung von Forskolin und seinen Derivaten durch Neurospora crassa
EP0497299A1 (de) Decarestrictine und verwandte Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0497300A1 (de) Neue Naturstoffe mit Zehnringlacton-Struktur, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19516521A1 (de) Cillianon, Antibiotikum aus Penicilin spe., und chemische Derivate davon, Verfahren zur Herstellung derselben
CH636886A5 (de) Verfahren zur herstellung von antibiotisch wirksamen, ungesaettigten oder substituierten methylaethern.

Legal Events

Date Code Title Description
PL Patent ceased